tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Radiopharm Theranostics Secures Strong Backing at AGM
Company AnnouncementsRadiopharm Theranostics Secures Strong Backing at AGM
2h ago
RAD
Radiopharm Theranostics Highlights Key Investor Considerations at AGM
PremiumCompany Announcements
Radiopharm Theranostics Highlights Key Investor Considerations at AGM
6h ago
RAD
Radiopharm Theranostics Appoints New Director
PremiumCompany Announcements
Radiopharm Theranostics Appoints New Director
24h ago
RAD
Radiopharm Theranostics Strengthens Board with Appointment of Bruce Goodwin
PremiumCompany Announcements
Radiopharm Theranostics Strengthens Board with Appointment of Bruce Goodwin
24h ago
RAD
Radiopharm receives approval to initiate Phase 1 trial of RAD 402
PremiumThe Fly
Radiopharm receives approval to initiate Phase 1 trial of RAD 402
2d ago
RADX
Radiopharm Theranostics Gains Approval for Phase 1 Trial of RAD 402 in Prostate Cancer
PremiumCompany AnnouncementsRadiopharm Theranostics Gains Approval for Phase 1 Trial of RAD 402 in Prostate Cancer
2d ago
RAD
Radiopharm announces 50% enrollment in Phase 2b trial of RAD101
Premium
The Fly
Radiopharm announces 50% enrollment in Phase 2b trial of RAD101
3d ago
RADX
Radiopharm Theranostics Achieves 50% Enrollment in Phase 2b Trial for Brain Metastases Imaging
Premium
Company Announcements
Radiopharm Theranostics Achieves 50% Enrollment in Phase 2b Trial for Brain Metastases Imaging
3d ago
RAD
Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204
PremiumThe Fly
Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204
8d ago
RADX
Radiopharm Theranostics Advances Phase 1 Trial for Innovative Cancer Treatment
PremiumCompany Announcements
Radiopharm Theranostics Advances Phase 1 Trial for Innovative Cancer Treatment
8d ago
RAD
Radiopharm Theranostics Announces Change in Equity Derivative Position
PremiumCompany Announcements
Radiopharm Theranostics Announces Change in Equity Derivative Position
14d ago
RAD
Radiopharm Theranostics Limited: Promising Financial and Clinical Outlook Justifies Buy Rating
PremiumRatings
Radiopharm Theranostics Limited: Promising Financial and Clinical Outlook Justifies Buy Rating
16d ago
RADX
Radiopharm Theranostics to Present at Deutsche Bank ADR Virtual Investor Conference
PremiumCompany AnnouncementsRadiopharm Theranostics to Present at Deutsche Bank ADR Virtual Investor Conference
17d ago
RAD
Radiopharm Theranostics Director Increases Shareholding
Premium
Company Announcements
Radiopharm Theranostics Director Increases Shareholding
17d ago
RAD
Radiopharm Theranostics Announces Change in Substantial Holding
Premium
Company Announcements
Radiopharm Theranostics Announces Change in Substantial Holding
23d ago
RAD
Radiopharm Theranostics Advances Clinical Programs with FDA Approval and Strategic Investments
PremiumCompany Announcements
Radiopharm Theranostics Advances Clinical Programs with FDA Approval and Strategic Investments
23d ago
RAD
Radiopharm Theranostics’ RAD301 Study: A Potential Game-Changer in Cancer Diagnostics
PremiumCompany Announcements
Radiopharm Theranostics’ RAD301 Study: A Potential Game-Changer in Cancer Diagnostics
23d ago
RAD
Medpace and Radiopharm Launch Promising Cancer Study with 177LuBetaBart
PremiumCompany Announcements
Medpace and Radiopharm Launch Promising Cancer Study with 177LuBetaBart
23d ago
MEDP
Medpace and Radiopharm Theranostics Advance Brain Metastases Imaging Study
PremiumCompany Announcements
Medpace and Radiopharm Theranostics Advance Brain Metastases Imaging Study
23d ago
MEDP
Radiopharm Theranostics Advances with Promising PD-L1 Targeted Therapy Study
PremiumCompany AnnouncementsRadiopharm Theranostics Advances with Promising PD-L1 Targeted Therapy Study
23d ago
RAD
Radiopharm Theranostics Advances with Promising HER2 Antibody Therapy Study
Premium
Company Announcements
Radiopharm Theranostics Advances with Promising HER2 Antibody Therapy Study
23d ago
RAD
Radiopharm Theranostics Announces Hybrid Annual General Meeting
Premium
Company Announcements
Radiopharm Theranostics Announces Hybrid Annual General Meeting
29d ago
RAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >